Editorial: Anti-infectives: Helicobacter pylori and peptic ulcer disease: Recent developments

References

• SLOMIANY BL, BILSKI J, SAROSIEK J, MURTY VLN, DWORKIN B, VAN HORN K, ZIELENSKI J, SLOMIANY A: Campylobacter pyloridis degrades mucin and under-mines gastric mucosal integrity. Biochem. Biophys, Res. Common. (1987) 144:307.
   PubMed Web of Science ®Google Scholar
• TIAZELL S, LEE A: Campylobacter pyloridis, urease, hy- drogen ion back diffusion and gastric ulcers. Lancet (1986) 11.15
   Google Scholar
• KOZOL R, MCCURDY B, CZANKO R: A neutrophil chemo-tactic factor present in H. pylori but absent in H. mustelae. Dig. Dis. Sci. (1993) 38:137141.
   Google Scholar
• CRAIG PM, TERRITO MC, KARNES WE, WALSH JI L Helico- bacter pylori secretes a chemotactic factor for mono-cytes and neutrophils. Gut (1992) 33:1020–1023.
   PubMed Web of Science ®Google Scholar
• SATOH K, KIMURA K, YASHIDA Y, KASANO T, KIHARA K, TANIGUCHI Y: A topographical relationship between Helicobacter pylori and gastritis: quantitative assess-ment of Helicobacter pylori in the gastric mucosa. Am. J. GastroenteroL (1991) 86:285–291.
   PubMed Web of Science ®Google Scholar
• NOACH LA, BOSMA NB, JANSEN J, HOEK FJ, VAN DEVEN-TER SJH: Mucosal tumor necrosis factor-a, interleukin-113 and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. (1994) 29:425–429.
   PubMed Web of Science ®Google Scholar
• GIONCHETTI P, VAIRA D, CAMPIERI M, HOLTON J, MENE-GA I 11 M, BELLUZZI A, BERTINELLI E, FARRETTI M, BRIG-NOLA C, MIGLIOLI M, BARBARA L: Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori positive dyspeptic patients. Am.J.Gastroenterol. (1994) 89:883–887.
   PubMed Web of Science ®Google Scholar
• DAVIES GR, BANATVALA N, COLLINS CE, SHEAFF MT,ABDII Y, CLEMENTS L, RAMPTON DS: Relationship be-tween infective load of Helicob acter pylori and reactive oxygen metabolite production in antral mucosa. Scand. J. Gastroenterol. (1994) 29:419–424.
   PubMed Web of Science ®Google Scholar
• KOZOL RA, DEKIINE N: Helicobacter pylori and the pathogenesis of duodenal ulcer. J. Lab. Chn. Med. (1994)124:623-626. An in depth review of current theories concerning H. pylori and u lc erogenes is.
   Google Scholar
• MADSEN _JE, VETVIK R, AASE S: Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with rani-tidine, misoprostol or an acid neutralizing agent. Scand. J. Gastroezzterol. (1991) 26:465–470.
   Google Scholar
• SATOII K, KIMURA K, YOSHIDA Y. KASANO T, KR IARA K,TANIGUCHI Y: Relationship between Helicobacter py-lori colonization and acute inflammation of the duode-nal mucosa. Am.]. Gastroenterol. (1993) 88:360–363.
   Google Scholar
• RANG _JY, WEE A: Helicobacter pylori and gastric acidoutput in peptic ulcer disease. Dig. Dis. Sci. (1991) 36:5–9.
   Google Scholar
• PETERSON WL, BA.RNETT CC, EVANS DJ, FELDIVIAN M,CARMODY T, IZICHARDSON C. WALSII J, GRAHAM DY: Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobac-ter pylori. Am. J. Gastroenterol. (1993) 88:2038–2043.
   Google Scholar
• CRABTREE JE, TAYLOR JD, WYATT JI, HEATLEY RV, SHALL-CROSS TM, TOMPKINS DS, RATHBONE EJ Mucosal IgA recognition of Helicobacter pylori 120 ItDa protein, peptic ulceration and gastric pathology. Lancet (1991) 338:332–335.
   PubMed Web of Science ®Google Scholar
• COVER TL, BLASER ML: Purification and characterizationof the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. (1992) 26:93–99.
   Google Scholar
• GO MF, GRAHAM DY: How does Helicobacter pyloricause duodenal ulcer disease: the bug, the host or both? J. Gastroenterol, Hepatol. (1994) 9(Suppl.):58–S10.
   Google Scholar
• CUTLER AF, HAVSTAD S, MA CK, BLASERMJ, PEREZ-PEREZ GI, SCHUBERT TT: Accuracy of invasive and non-inva-sive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 109:136-141. A thorough review of diagnostic tests available for the diagnosis of H. pylori infection.
   Google Scholar
• PEURA DA: Helicobacter pylori: a diagnostic dilemmaand a dilemma of diagnosis. Gastroenterology (1995) 109:313–315.
   PubMed Web of Science ®Google Scholar
• LOGAN RPH, WALKER MM, MISIEWICZ JJ, GUMMETT PA,KARIM QN, BARON JH: Changes in the intragastric dis-tribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 36:12–16.
   PubMed Web of Science ®Google Scholar
• GRAHAM DY, LEW GM, KLEIN PD, EVANS DG, EVANS DJ, SAEED ZA, MALATY HM: Effected treatment of Helico-bacter pylori infection on the long term recurrence of gastric or duodenal ulcer. Ann. Int. Med. (1992) 116:705-708. One of the early prospective studies demonstrating a decrease in ulcer recurrence following the eradication of H. pylori.
   Google Scholar
• SUNG JJY, CHUNG SC, LING TKW, YUNG MY, LEUNG VKS, NG EK, LI MKK, CHENG AFB, LI AKC: Antibacterial treat-ment of gastric ulcers associated with Helicobacter pylori. New Engl,J. Med. (1995) 332:139–142.
   PubMed Web of Science ®Google Scholar
• BUT(E1Th A, GLUPCZYNSKI Y: Helicobacter pylori: the •Place of the new macrolides in the eradication of the bacteria in peptic ulcer disease. Infection (1995) 23\(Suppl. 1.):844–852.
   Google Scholar
• NOACH LA, LANGENBERG WL, BERTOLA MA, DANKERT J, TYTGAT NJ: Impact of metronidazole resistance on the eradication of HelicobacterScand. J. Infect. Dis.(1994) 26:321–327.
   Web of Science ®Google Scholar
• GRAHAM DY: Letter to the Editor. Am.]. Gastroenterol.(1995) 90:674–675.
   PubMedGoogle Scholar
• BAYERDORFFER E, MIEHLKE 5, MANNES GA, SOMMER A,HOCHTER W, WEINGART J, IIELDWEIN W, KLANN H, SIMON T, SCHMITT W, BASTLEIN E, EIMILLER A, HAIZ R, LEHN N, DIRSCHEDLY P. STOLTE M: Double-blind trial of omeprazole and amoxacillin to cure Helicobacter py-lori infection in patients with duodenal ulcers. Gas-troenterology (1995) 108:1412–1417.
   Google Scholar
• NAKAJIMA M, SIJNAIRI M, TANAKA N Cl al.: Effects of sucralfate, an anti-ulcer agent on Helicobacter pylori. Gastroenterology (1992) 102:A131.
   Google Scholar
• SUNG JJY, LEUNG VKS, CI UNG SCS, LING TKW, SUEN R, CHENG AFB, LI AKC: Triple therapy with sucralfate, tetracycline and metronidazole for Helicobacter pylori associated duodenal ulcers. Am. J. Gastromzterol. (1995) 90:1424–1427.
   PubMed Web of Science ®Google Scholar
• KODAMA R, FUJIOKA T, FUJIYAMA K, KAWASAKI H, KUBOTA T, NASU M: Combination therapy with clarithromycin and sofalcone for eradication ofHelico-bacterpylori. Eur.J. Gastroenterol. Hepatol. (1994) 6\(Suppl. 1):S125–S128.
   Google Scholar
• WEBB DD, CIOCIOLA AA, PERSCHY TB, GOODWIN BB:Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Heti-cobacter pylori in infected volunteers. Am. J Gastroen-terol. (1995) 90:1273–1277.
   PubMed Web of Science ®Google Scholar
• LOGAN RPH, GUMMETT PA, MISIEWICZ JJ, KARIM QN,WALKER MM, BARON JH: One week's anti-Helicobacter • pylori treatment for duodenal ulcer. Gut (1994) 35:15–18.
   PubMed Web of Science ®Google Scholar
• HOSKING SW, LING KW, CHUNG SCS, YUNG MY, CHENG seAFB, SUNG JJY, LI AKC: Duodenal ulcer healing byeradication of Helicobacter pylori without anti-acid treatment: randomized prospective triaL Lancet (1994) 343:508–510.
   Google Scholar